LumiraDx Investor Presentation Deck

Consolidate Multiple POC Instruments to a Single Lab Comparable Platform INSERT TEST X X X BD Veritor System Coagulation Respiratory Immunoassay lumiraDx™ Diabetes, Inflammation NEAR TERM Able to move most European customers from 3 → 1 Platform with INR, COVID Ag, Flu A/B, RSV, CRP and HbA1c Respiratory Molecular Copyright © 2023 LumiraDx Ltd. All Rights Reserved, Worldwide. 20x Diabetes, Cardiovascular 6 Cardiac, Blood gas, Metabolic 18-24 MONTHS Expect to be able to move most US and European customers 6 → 1 Platform with US authorizations and addition of molecular respiratory, lipids, electrolytes, and cardiac content 24

View entire presentation